Skip to main content

Grifols SA

GRFS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438569

No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; 164 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Other share classesGIFLFGIFOFGIKLY

Q2 2024 vs. Q1 2024

How the institutions holding Grifols SA changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of GRFS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders130129−1
Shares135.9M144.7M+8.75M (+6.4%)
Value$907.9M$912.2M+$4.33M (+0.5%)

New holders (17)

Institutions that held Grifols SA at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to GRFS in Q2 2024
InstitutionSharesValue% of portfolio
Highland Peak Capital, LLC950,211$5.99M4.14%
Soros Fund Management LLCSuperinvestorSoros Fund Management752,000$4.74M0.11%
Oasis Management Co Ltd.320,041$2.02M0.68%
National Asset Management, Inc.56,950$359.1K0.01%
Campbell & CO Investment Adviser LLC37,495$236.4K0.02%
Capstone Investment Advisors, LLC31,520$198.7K0.00%
Charles Schwab Investment Management Inc29,242$184.4K0.00%
Engineers Gate Manager LP27,780$175.2K0.00%
Cresset Asset Management, LLC14,887$93.9K0.00%
AQR Capital Management LLC14,107$88.9K0.00%
HighTower Advisors, LLC12,384$79.0K0.00%
Huntington National Bank10,000$63.0K0.00%
Glenmede Trust Co NA6,874$43.3K0.00%
Mirae Asset Global Investments Co., Ltd.3,642$22.9K0.00%
Farther Finance Advisors, LLC541$3.40K0.00%
Family Firm, Inc.35$2210.00%
Mendota Financial Group, LLC8$510.00%

Sold out (18)

Institutions that held Grifols SA at the end of Q1 2024 and filed for Q2 2024 without it.